
Chandan Healthcare Ltd is Rated Sell
2026-07-16 10:11:13Chandan Healthcare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 07 Jul 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 16 July 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Chandan Healthcare Ltd Technical Momentum Shifts Amid Mixed Market Returns
2026-07-14 08:07:03Chandan Healthcare Ltd, a micro-cap player in the hospital sector, has experienced a subtle shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a modest day gain of 0.28%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators, reflecting cautious investor sentiment amid broader market challenges.
Read full news article
Chandan Healthcare Ltd Faces Technical Momentum Shift Amid Mixed Market Returns
2026-07-13 08:04:44Chandan Healthcare Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend, reflecting a complex interplay of technical indicators. Despite a recent downgrade in its Mojo Grade to Sell, the stock’s price action and momentum oscillators reveal a nuanced picture for investors navigating the hospital sector’s micro-cap landscape.
Read full news article
Chandan Healthcare Ltd Shows Technical Momentum Shift Amid Mixed Returns
2026-07-10 08:05:11Chandan Healthcare Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a mildly bullish outlook. This change is reflected in key indicators such as the MACD, Bollinger Bands, and Dow Theory signals, signalling a potential positive trend reversal despite the company’s micro-cap status and a recent downgrade in its Mojo Grade to Sell.
Read full news article
Chandan Healthcare Ltd Faces Technical Downturn Amid Price Momentum Shift
2026-07-08 08:06:39Chandan Healthcare Ltd, a micro-cap player in the hospital sector, has experienced a notable shift in its technical momentum, signalling a transition from a sideways trend to a mildly bearish phase. This change is underscored by a series of technical indicators, including MACD, RSI, and moving averages, which collectively suggest increasing downside pressure on the stock currently priced at ₹234.10.
Read full news article
Chandan Healthcare Ltd is Rated Hold
2026-07-05 10:10:45Chandan Healthcare Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 01 July 2026. While this rating change occurred recently, the analysis and financial metrics discussed here reflect the company’s current position as of 05 July 2026, providing investors with the most up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Chandan Healthcare Ltd Technical Momentum Shifts Amid Market Volatility
2026-07-03 08:06:20Chandan Healthcare Ltd, a micro-cap player in the hospital sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent downgrade from a Sell to a Hold rating by MarketsMOJO on 1 July 2026, the stock’s price action and technical indicators reveal a complex picture that investors should carefully analyse.
Read full news article
Chandan Healthcare Ltd Technical Momentum Shifts to Mildly Bullish Amid Mixed Signals
2026-07-02 08:10:37Chandan Healthcare Ltd, a micro-cap player in the hospital sector, has exhibited a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend. Despite a day decline of 2.42%, the stock’s weekly and monthly technical indicators suggest a cautiously optimistic outlook, contrasting with its recent price performance and broader market returns.
Read full news article
Chandan Healthcare Ltd Sees Mixed Technical Signals Amid Mild Momentum Shift
2026-06-29 08:03:54Chandan Healthcare Ltd, a micro-cap player in the hospital sector, has exhibited a nuanced shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. Despite a notable 4.00% gain on 29 Jun 2026, the stock’s technical indicators present a complex picture, reflecting both cautious optimism and lingering bearish pressures.
Read full news articleCorporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






